Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteoporosis: outstanding issues

P D Delmas1, A D Woolf

  • 1INSERM Research Unit 403, Hôpital E. Herriot, Lyon, France.

Bailliere'S Clinical Rheumatology
|August 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Younger people with rheumatoid arthritis are at increased risk of fracture even before age 50 years: a population-based cohort study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

Building multidisciplinary health workforce capacity to support the implementation of integrated, people-centred Models of Care for musculoskeletal health.

Best practice & research. Clinical rheumatology·2016
Same author

Hip fracture, mortality risk, and cause of death over two decades.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2016
Same author

Vertebral Scheuermann's disease in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and over.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2015
Same author

Mortality and incident vertebral fractures after 3 years of follow-up among geriatric patients.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2012
Same author

Femoral neck shaft angle in men with fragility fractures.

Journal of osteoporosis·2011
Same journal

Regional soft tissue pains: alias myofascial pain?

Bailliere's clinical rheumatology·1999
Same journal

The knee

Bailliere's clinical rheumatology·1999
Same journal

The elbow, forearm, wrist and hand

Bailliere's clinical rheumatology·1999
Same journal

Shoulder disorders: a state-of-the-art review

Bailliere's clinical rheumatology·1999
Same journal

The neck

Bailliere's clinical rheumatology·1999
Same journal

Treatment options for regional musculoskeletal pain: what is the evidence?

Bailliere's clinical rheumatology·1999
See all related articles

Recent advances in osteoporosis treatment show promise, but new bone-forming agents are needed to reduce fracture rates. Combined therapies are also under investigation for improved osteoporosis management.

Area of Science:

  • Bone biology and metabolic diseases.
  • Pharmacological interventions for skeletal health.

Background:

  • Osteoporosis knowledge and treatment have significantly advanced.
  • Current anti-resorption therapies reduce fracture incidence but have limitations.

Purpose of the Study:

  • Review key aspects of osteoporosis epidemiology, pathogenesis, and diagnosis.
  • Highlight areas needing further investigation.
  • Discuss novel therapeutic strategies, including bone-forming agents and combination therapies.

Main Methods:

  • Literature review of recent advances in osteoporosis.
  • Analysis of current treatment efficacy and limitations.
  • Exploration of emerging therapeutic targets and agents.

Main Results:

Related Experiment Videos

  • Significant progress in understanding osteoporosis and its management.
  • Established efficacy of anti-resorption therapies like hormone replacement therapy and bisphosphonates.
  • Lack of approved bone-forming agents proven to decrease fracture rates.

Conclusions:

  • Further research is crucial for osteoporosis epidemiology, pathogenesis, and diagnosis.
  • Development of effective bone-forming agents is a critical unmet need.
  • Combined therapeutic approaches may offer improved outcomes for osteoporosis patients.